These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 2961878)

  • 1. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
    Hensler JG; Cotterell DJ; Dubocovich ML
    J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological differences between the D-2 autoreceptor and the D-1 dopamine receptor in rabbit retina.
    Dubocovich ML; Weiner N
    J Pharmacol Exp Ther; 1985 Jun; 233(3):747-54. PubMed ID: 4009487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.
    Saller CF; Salama AI
    J Pharmacol Exp Ther; 1986 Mar; 236(3):714-20. PubMed ID: 3005552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH; Gnegy ME
    Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of rat retinal dopamine receptors.
    Qu ZX; Fertel R; Neff NH; Hadjiconstantinou M
    J Pharmacol Exp Ther; 1989 Feb; 248(2):621-5. PubMed ID: 2493095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light modulates dopamine-regulated Walsh inhibitor activity and dopamine-dependent cyclic AMP accumulation in the rabbit retina.
    Nowak JZ; Zawilska J; Sek B; Schorderet M
    Pol J Pharmacol Pharm; 1990; 42(5):457-70. PubMed ID: 1983030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
    Barton AC; Sibley DR
    Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of D1 dopamine receptors in the bovine pineal gland with [3H]SCH 23390.
    Simonneaux V; Murrin LC; Ebadi M
    J Pharmacol Exp Ther; 1990 Apr; 253(1):214-20. PubMed ID: 2139469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential localization of dopamine D1 and D2 receptors in rat retina.
    Tran VT; Dickman M
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1620-6. PubMed ID: 1532792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of [3H]dopamine release from rabbit retina.
    Dubocovich ML
    Fed Proc; 1984 Sep; 43(12):2714-8. PubMed ID: 6468669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
    Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABAergic modulation of D-1 dopamine receptor-mediated 3H-acetylcholine release from rabbit retina.
    Hensler JG; Dubocovich ML
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):661-8. PubMed ID: 3216899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D1-dopamine receptor activation mediates [3H]acetylcholine release from rabbit retina.
    Hensler JG; Dubocovich ML
    Brain Res; 1986 Nov; 398(2):407-12. PubMed ID: 2948615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]SCH 23390 labels both dopamine-1 and 5-hydroxytryptamine1c receptors in the choroid plexus.
    Nicklaus KJ; McGonigle P; Molinoff PB
    J Pharmacol Exp Ther; 1988 Oct; 247(1):343-8. PubMed ID: 2971798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H; Lovenberg T; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.